$5.56 Billion is the total value of Eventide Asset Management's 155 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 45.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
TT | Buy | TRANE TECHNOLOGIES PLC | $160,424,704 | +6.3% | 790,620 | +0.2% | 2.88% | +13.0% |
ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $156,749,622 | -19.2% | 7,814,039 | +13.6% | 2.82% | -14.1% |
FLYW | Buy | FLYWIRE CORPORATION | $129,832,737 | +2.8% | 4,071,268 | +0.1% | 2.33% | +9.3% |
EXAS | Buy | EXACT SCIENCES CORP | $127,438,371 | -27.3% | 1,868,050 | +0.0% | 2.29% | -22.7% |
MIRM | Buy | MIRUM PHARMACEUTICALS INC | $125,091,097 | +39.8% | 3,958,579 | +14.4% | 2.25% | +48.7% |
ROP | Buy | ROPER TECHNOLOGIES INC | $114,826,178 | +0.8% | 237,107 | +0.1% | 2.06% | +7.3% |
POOL | Buy | POOL CORP | $102,235,954 | -3.2% | 287,099 | +1.9% | 1.84% | +3.0% |
CRWD | Buy | CROWDSTRIKE HLDGS INCcl a | $83,588,568 | +14.4% | 499,394 | +0.4% | 1.50% | +21.7% |
DHI | Buy | D R HORTON INC | $80,730,819 | -3.6% | 751,194 | +9.1% | 1.45% | +2.5% |
HZNP | Buy | HORIZON THERAPEUTICS PUB L | $79,795,095 | +12.5% | 689,732 | +0.0% | 1.43% | +19.6% |
TTD | Buy | THE TRADE DESK INC | $79,137,972 | +1.8% | 1,012,642 | +0.6% | 1.42% | +8.2% |
XMTR | Buy | XOMETRY INC | $74,021,135 | +9.5% | 4,359,313 | +36.6% | 1.33% | +16.5% |
LAD | Buy | LITHIA MTRS INC | $73,098,310 | -1.6% | 247,514 | +1.3% | 1.31% | +4.6% |
EVH | Buy | EVOLENT HEALTH INCcl a | $71,858,336 | -10.1% | 2,638,940 | +0.0% | 1.29% | -4.4% |
SWAV | Buy | SHOCKWAVE MED INC | $70,823,255 | +2.3% | 355,717 | +46.7% | 1.27% | +8.8% |
COUR | Buy | COURSERA INC | $69,039,178 | +55.9% | 3,693,910 | +8.6% | 1.24% | +65.7% |
DDOG | Buy | DATADOG INC | $66,580,687 | +36.5% | 730,933 | +47.4% | 1.20% | +45.3% |
COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $58,810,315 | +4.0% | 2,631,334 | +0.0% | 1.06% | +10.6% |
Buy | TOAST INCcl a | $54,805,366 | +51.4% | 2,926,074 | +82.4% | 0.98% | +60.9% | |
TREX | Buy | TREX CO INC | $54,390,324 | -6.0% | 882,530 | +0.0% | 0.98% | 0.0% |
ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $53,884,014 | +4.9% | 575,438 | +0.0% | 0.97% | +11.5% |
DV | Buy | DOUBLEVERIFY HLDGS INC | $53,678,758 | -26.8% | 1,920,528 | +1.9% | 0.96% | -22.2% |
TMDX | Buy | TRANSMEDICS GROUP INC | $50,663,241 | +794.3% | 925,356 | +1271.7% | 0.91% | +849.0% |
LNG | Buy | CHENIERE ENERGY INC | $49,989,641 | +8.9% | 301,215 | +0.0% | 0.90% | +15.7% |
TRGP | Buy | TARGA RES CORP | $49,259,341 | +65.2% | 574,654 | +46.7% | 0.88% | +75.6% |
MPWR | Buy | MONOLITHIC PWR SYS INC | $45,425,688 | -13.6% | 98,324 | +1.0% | 0.82% | -8.2% |
FIVN | Buy | FIVE9 INC | $44,627,608 | -21.9% | 694,053 | +0.1% | 0.80% | -17.0% |
CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $44,032,000 | -5.8% | 1,600,000 | +16.1% | 0.79% | +0.1% |
ASML | Buy | ASML HOLDING N V | $41,142,036 | -18.1% | 69,891 | +0.9% | 0.74% | -13.0% |
LSCC | Buy | LATTICE SEMICONDUCTOR CORP | $36,778,298 | -10.5% | 428,003 | +0.0% | 0.66% | -4.9% |
Buy | MARINUS PHARMACEUTICALS INC | $36,466,476 | +5.8% | 4,529,997 | +42.8% | 0.66% | +12.5% | |
SNPS | Buy | SYNOPSYS INC | $36,260,925 | +6.5% | 79,005 | +1.0% | 0.65% | +13.2% |
MNDY | New | MONDAY COM LTD | $32,419,899 | – | 203,617 | +100.0% | 0.58% | – |
KLAC | Buy | KLA CORP | $30,746,273 | +4.4% | 67,035 | +10.4% | 0.55% | +11.0% |
CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $30,298,577 | +286.7% | 1,018,782 | +134.3% | 0.54% | +312.9% |
ORLY | Buy | OREILLY AUTOMOTIVE INC | $27,931,086 | -4.0% | 30,732 | +1.0% | 0.50% | +2.2% |
SGEN | Buy | SEAGEN INC | $27,789,529 | +10.2% | 130,990 | +0.0% | 0.50% | +17.1% |
Buy | AURA BIOSCIENCES INC | $27,133,398 | -25.2% | 3,024,905 | +3.0% | 0.49% | -20.4% | |
FANG | Buy | DIAMONDBACK ENERGY INC | $26,283,601 | +75.9% | 169,703 | +49.2% | 0.47% | +86.6% |
AKRO | Buy | AKERO THERAPEUTICS INC | $25,991,848 | +46.8% | 513,876 | +35.5% | 0.47% | +56.2% |
INSP | Buy | INSPIRE MED SYS INC | $24,822,860 | -29.3% | 125,090 | +15.6% | 0.45% | -24.9% |
AJG | Buy | GALLAGHER ARTHUR J & CO | $24,743,853 | +15.5% | 108,559 | +11.2% | 0.44% | +22.9% |
AXSM | New | AXSOME THERAPEUTICS INC | $24,231,702 | – | 346,712 | +100.0% | 0.44% | – |
FERG | New | FERGUSON PLC NEW | $24,012,949 | – | 146,002 | +100.0% | 0.43% | – |
SHW | Buy | SHERWIN WILLIAMS CO | $23,749,491 | -2.9% | 93,117 | +1.1% | 0.43% | +3.4% |
ISRG | Buy | INTUITIVE SURGICAL INC | $22,330,664 | -13.0% | 76,399 | +1.8% | 0.40% | -7.6% |
PNR | Buy | PENTAIR PLC | $21,383,688 | +0.2% | 330,250 | +0.0% | 0.38% | +6.4% |
DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $21,047,250 | +58.8% | 1,425,000 | +38.9% | 0.38% | +68.8% |
PCVX | New | VAXCYTE INC | $20,035,140 | – | 393,000 | +100.0% | 0.36% | – |
BILL | New | BILL HOLDINGS INC | $19,891,544 | – | 183,214 | +100.0% | 0.36% | – |
BEPC | Buy | BROOKFIELD RENEWABLE CORPcl a sub vtg | $18,581,079 | -24.0% | 776,152 | +0.0% | 0.33% | -19.1% |
ROL | New | ROLLINS INC | $18,303,944 | – | 490,328 | +100.0% | 0.33% | – |
NOVT | Buy | NOVANTA INC | $18,077,456 | -22.1% | 126,028 | +0.0% | 0.32% | -17.1% |
CMS | Buy | CMS ENERGY CORP | $17,598,423 | -6.8% | 331,358 | +3.1% | 0.32% | -0.9% |
HLI | New | HOULIHAN LOKEY INCcl a | $16,028,580 | – | 149,632 | +100.0% | 0.29% | – |
RPHM | Buy | RENEO PHARMACEUTICALS INC | $15,825,051 | +37.8% | 2,078,142 | +18.8% | 0.28% | +46.4% |
VRNA | New | VERONA PHARMA PLCsponsored ads | $13,855,000 | – | 850,000 | +100.0% | 0.25% | – |
ESI | Buy | ELEMENT SOLUTIONS INC | $13,408,926 | +16.7% | 683,780 | +14.2% | 0.24% | +24.2% |
INZY | New | INOZYME PHARMA INC | $13,125,000 | – | 3,125,000 | +100.0% | 0.24% | – |
Buy | GXO LOGISTICS INCORPORATED | $12,913,264 | -6.6% | 220,175 | +0.0% | 0.23% | -0.9% | |
EQT | New | EQT CORP | $12,831,396 | – | 316,200 | +100.0% | 0.23% | – |
DNLI | Buy | DENALI THERAPEUTICS INC | $12,828,766 | +38.7% | 621,850 | +98.4% | 0.23% | +48.1% |
EGP | Buy | EASTGROUP PPTYS INC | $11,066,585 | +91.7% | 66,454 | +99.8% | 0.20% | +103.1% |
ARDX | New | ARDELYX INC | $10,995,600 | – | 2,695,000 | +100.0% | 0.20% | – |
RVMD | Buy | REVOLUTION MEDICINES INC | $9,992,480 | +3.6% | 361,000 | +0.1% | 0.18% | +10.4% |
FREQ | New | FREQUENCY THERAPEUTICS INC | $9,999,999 | – | 3,597,122 | +100.0% | 0.18% | – |
IDYA | New | IDEAYA BIOSCIENCES INC | $9,038,300 | – | 335,000 | +100.0% | 0.16% | – |
INBX | New | INHIBRX INC | $7,964,377 | – | 434,026 | +100.0% | 0.14% | – |
EQIX | Buy | EQUINIX INC | $7,702,714 | +3.2% | 10,606 | +11.4% | 0.14% | +9.5% |
ANAB | New | ANAPTYSBIO INC | $7,668,920 | – | 427,000 | +100.0% | 0.14% | – |
GPI | New | GROUP 1 AUTOMOTIVE INC | $4,630,142 | – | 17,231 | +100.0% | 0.08% | – |
VST | New | VISTRA CORP | $3,753,919 | – | 113,138 | +100.0% | 0.07% | – |
INTA | New | INTAPP INC | $2,882,150 | – | 85,983 | +100.0% | 0.05% | – |
New | TURNSTONE BIOLOGICS CORP | $2,790,769 | – | 708,317 | +100.0% | 0.05% | – | |
Buy | ARTERIS INC | $2,597,640 | -4.5% | 399,023 | +0.1% | 0.05% | +2.2% | |
MDB | New | MONGODB INCcl a | $2,521,665 | – | 7,291 | +100.0% | 0.04% | – |
PXD | New | PIONEER NAT RES CO | $1,592,618 | – | 6,938 | +100.0% | 0.03% | – |
NOW | Buy | SERVICENOW INC | $811,051 | +59.3% | 1,451 | +60.2% | 0.02% | +66.7% |
ALV | New | AUTOLIV INC | $815,256 | – | 8,450 | +100.0% | 0.02% | – |
SPGI | New | S&P GLOBAL INC | $831,308 | – | 2,275 | +100.0% | 0.02% | – |
SHOP | New | SHOPIFY INCcl a | $729,601 | – | 13,370 | +100.0% | 0.01% | – |
EW | Buy | EDWARDS LIFESCIENCES CORP | $678,528 | +40.8% | 9,794 | +91.7% | 0.01% | +50.0% |
New | LINDE PLC | $684,752 | – | 1,839 | +100.0% | 0.01% | – | |
ALGN | Buy | ALIGN TECHNOLOGY INC | $587,741 | +41.1% | 1,925 | +63.4% | 0.01% | +57.1% |
TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $595,178 | +62.0% | 6,849 | +88.2% | 0.01% | +83.3% |
WM | New | WASTE MGMT INC DEL | $483,692 | – | 3,173 | +100.0% | 0.01% | – |
ZTS | New | ZOETIS INCcl a | $389,019 | – | 2,236 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LOWES COS INC | 40 | Q3 2023 | 3.2% |
PALO ALTO NETWORKS INC | 40 | Q3 2023 | 3.6% |
ASML HOLDINGS NV | 40 | Q3 2023 | 1.9% |
NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
REPLIGEN CORP | 40 | Q3 2023 | 0.5% |
VERACYTE INC | 38 | Q3 2023 | 1.5% |
LAM RESEARCH CORP | 35 | Q3 2023 | 3.4% |
XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.6% |
MAGNA INTL INC | 33 | Q4 2021 | 2.5% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Cogent Biosciences, Inc. | February 14, 2023 | 2,589,778 | 3.7% |
ESSA Pharma Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Freeline Therapeutics Holdings plc | February 14, 2023 | 5,920,765 | 9.1% |
KnowBe4, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Praxis Precision Medicines, Inc. | February 14, 2023 | 3,518,062 | 7.5% |
Prometheus Biosciences, Inc. | February 14, 2023 | 1,032,938 | 2.2% |
SUTRO BIOPHARMA, INC.Sold out | February 14, 2023 | 0 | 0.0% |
Vital Farms, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Zymeworks Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Entasis Therapeutics Holdings Inc. | February 14, 2022 | 590,602 | 1.2% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-02-20 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.